← Back to patent-cliff list
CAS 5451-40-1
2,6-dichloro-9H-purine
Codes: REGA-012, ABAC-032
Application context (from source-drug indications)
Cardiovascular contrast agentRegadenoson HydrateDiagnostic agentRegadenoson HydrateContrast imagingRegadenoson HydrateCoronary artery lesionRegadenoson HydrateIschaemic heart diseaseRegadenoson HydratePneumoniaRegadenoson HydrateHIV infectionAbacavir Sulfate艾滋病痴呆综合征Abacavir Sulfate
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Regadenoson Hydrate | Tier C — Watch / trade | - |
| Abacavir Sulfate | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
2,6-dichloro-9H-purine→(2S,3R,4R,5R)-2-acetoxy-5-((benzoyloxy)methyl)tetrahydrofuran-3,4-diyl dibenzoate→(2R,3R,4R,5R)-2-((benzoyloxy)methyl)-5-(2,6-dichloro-9H-purin-9-yl)tetrahydrofuran-3,4-diyl dibenzoate→(2R,3R,4S,5R)-2-(6-amino-2-chloro-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol→N-methyl-1H-pyrazole-4-carboxamide
6-azabicyclo[3.2.0]hept-3-en-7-one→(1S,5R)-6-azabicyclo[3.2.0]hept-3-en-7-one→(1S,5R)-6-tosyl-6-azabicyclo[3.2.0]hept-3-en-7-one→2,6-dichloro-9H-purine→(1S,4R)-4-(2,6-dichloro-9H-purin-9-yl)-N-tosylcyclopent-2-enecarboxamide→(1S,4R)-4-(2,6-dichloro-9H-purin-9-yl)-N-methyl-N-tosylcyclopent-2-enecarboxamide→((1S,4R)-4-(2-chloro-6-(cyclopropylamino)-9H-purin-9-yl)cyclopent-2-en-1-yl)methanol
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.